1.
PONDEL, Kamil, KAWAŁKO, Kinga, BIELEWICZ, Krzysztof, CHMURA, Anna and KARAŚ, Anna. Effect of glucagon-like peptide-1 (GLP-1) agonists on the example of semaglutide on the cardiovascular system and their role in the treatment of obesity. Journal of Education, Health and Sport. Online. 30 August 2022. Vol. 12, no. 9, pp. 55-60. [Accessed 25 December 2025]. DOI 10.12775/JEHS.2022.12.09.007.